Start for free
Start for free
Proxima Ventures Ltd logo

Proxima Ventures Ltd

Asia, Tel Aviv, Israel, Tel Aviv

Description

Proxima Investments specializes in the management of investment portfolios for a variety of clients in Israel and abroad.

Investor Profile

Proxima Ventures Ltd has made 7 investments, with 1 in the past 12 months and 14% as lead.

Stage Focus

  • Seed (43%)
  • Series B (29%)
  • Series Unknown (14%)
  • Series A (14%)

Country Focus

  • United States (43%)
  • Israel (29%)
  • China (14%)
  • France (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Oncology
  • Cloud Computing
  • Ios
  • Mobile Devices
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Proxima Ventures Ltd frequently co-invest with?

CICC
CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
Gaingels
Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 3
China Asset Management
China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
CL
China Life Healthcare Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Bessemer Venture Partners
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
CD Capital
CD Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Giza Venture Capital
Giza Venture Capital
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2
Mana Ventures
Mana Ventures
North America, California, United States, San Francisco
Co-Investments: 3
ABC International
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

Which angels does Proxima Ventures Ltd often collaborate with?

JB
John Ballantyne
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by Proxima Ventures Ltd?

VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedSep 23, 2024
Amount Raised: $4,500,000
VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedSep 20, 2023
Amount Raised: $3,125,000
VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedJul 27, 2022
Amount Raised: $2,500,000
Jenscare Biotech

Ningbo, Zhejiang, China

Ningbo Jenscare Scientific is a medical device company.

BiotechnologyHealth Care
Series UnknownMay 28, 2021
HiFiBiO

Paris, Ile-de-France, France

HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series BMay 16, 2018
Amount Raised: $37,500,000
Soluto

Tel Aviv, Tel Aviv, Israel

Soluto is an all-in-one support and digital protection service that enables users to contact premier support technicians.

Cloud ComputingiOSMobile Devices
Series BJun 23, 2011
Amount Raised: $10,200,000
Soluto

Tel Aviv, Tel Aviv, Israel

Soluto is an all-in-one support and digital protection service that enables users to contact premier support technicians.

Cloud ComputingiOSMobile Devices
Series ANov 3, 2009
Amount Raised: $6,200,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator